Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

T. Rowe Price Value

American Funds Invmt Co of Amer A

Capital Group Investment Co of Amer Comp

Vanguard Value Index Inv

JHancock Disciplined Value Mid Cap I

BGF World Healthscience A2

The Health Care Select Sector SPDR® ETF

Vanguard Mid-Cap Value ETF

JHancock Disciplined Value I

Vanguard Institutional Index I

Vanguard Mid Cap Index Institutional

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

T. Rowe Price U.S. Value Equity Tr-Z

Pacer US Cash Cows 100 ETF

Vanguard Health Care Inv

iShares Core S&P 500 ETF

T. Rowe Price US Value Equity Composite

Vanguard Group Inc

Walgreens Boots Alliance Inc

Bank of America Corp

Morgan Stanley - Brokerage Accounts

Capital Research Global Investors

Amvescap Plc.

Bessemer Group Inc

Northern Trust Corp

Pacer Advisors, INC.

Legal & General Group PLC

Two Sigma Advisers, LLC

NORGES BANK

BlackRock Inc

T. Rowe Price Associates, Inc.

State Street Corp

Wellington Management Company LLP

Boston Partners Global Investors, Inc

Geode Capital Management, LLC

FMR Inc

JPMorgan Chase & Co

Cencora Inc.

Mr. Steven H. Collis

Executive Chairman

Dr. Robert P. Mauch Ph.D., PharmD

President, CEO, COO, Executive VP & Director

Mr. James F. Cleary Jr.

Executive VP & CFO

Ms. Elizabeth S. Campbell J.D.

Executive VP & Chief Legal Officer

Mr. Lazarus  Krikorian

Senior VP, Chief Accounting Officer & Corporate Controller

Mr. Pawan Singh Verma

Executive VP, Chief Data & Information Officer

Mr. Bennett S. Murphy

Senior Vice President of Investor Relations

Ms. Jennifer E. Dubas

Senior VP & Chief Compliance Officer

Ms. Silvana  Battaglia

Executive VP & Chief Human Resources Officer

Mr. Richard  Tremonte

EVP & President of U.S. Pharmaceuticals

COR's next earnings is on January 29, 2025 (Before Market Open)

COR's latest dividend is 0.51 USD on August 9, 2024

Cencora Inc. (COR) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Cencora Inc. (COR) Earnings Report Date and History | NYSE

COR's next earnings is on January 29, 2025 (Before Market Open)

When is the earnings report for COR?

COR Earnings History

COR's latest dividend is 0.51 USD on August 9, 2024

COR Stock Discussion Forum and Message Board

News for NYSE: COR